Παραπομπή APA

Sakugawa, C., Haruyama, Y., Tanaka, H., Fukushima, T., Kawaguchi, M., & Kataoka, H. (2017). Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma. BMC Res Notes.

Παραπομπή Chicago Style

Sakugawa, Chihiro, Yukihiro Haruyama, Hiroyuki Tanaka, Tsuyoshi Fukushima, Makiko Kawaguchi, και Hiroaki Kataoka. "Prognostic Significance of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) Immunoreactivity in Pancreatic Ductal Adenocarcinoma." BMC Res Notes 2017.

Παραπομπή MLA

Sakugawa, Chihiro, et al. "Prognostic Significance of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) Immunoreactivity in Pancreatic Ductal Adenocarcinoma." BMC Res Notes 2017.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.